Suzanne Elliott

Suzanne Elliott has a strong background in quality assurance and pharmacovigilance in the pharmaceutical industry. Suzanne has held various senior positions in different companies throughout their career. Currently, as the Global Head of Global Patient Safety Quality Management at Argenx, they are responsible for overseeing patient safety and quality management at a global level. Prior to joining Argenx, Suzanne worked as the Senior Director of Drug Safety & Pharmacovigilance Quality Management at Ultragenyx Pharmaceutical Inc. Suzanne also served as the Director of Quality Assurance Pharmacovigilance at Merck and as the Director of Pharmacovigilance Quality Assurance Leader at Jazz Pharmaceuticals. Suzanne has held similar positions at Vertex Pharmaceuticals, Shire, and AstraZeneca. Suzanne began their career as a Drug Safety Associate at DuPont and later worked as a Quality Assurance Specialist at Defense Logistics Agency. Suzanne has extensive experience in ensuring compliance and process quality in the pharmaceutical industry.

Suzanne Elliott attended the Wharton School from 2017 to 2018 for an Executive Development Program. Prior to that, they earned a Masters of Science in Regulatory Affairs/Quality Assurance from Temple University from 2000 to 2002. Suzanne also holds a BS in Health Sciences from Buffalo State University, which they completed from 1995 to 1997. Suzanne began their education at Mohawk College, where they obtained an RN degree in Nursing from 1994 to 1995. Suzanne completed their high school education at Sharon Hill High School.